Hungry Jack's Partners with Trintech to Modernize Financial Operations

Hungry Jack's Partners with Trintech to Modernize Financial Operations

Leading Australian quick-service restaurant brand leverages Trintech to automate high-volume transaction matching DALLAS and SYDNEY, Aug. 12, 2026 /PRNewswire/ -- Trintech, the trusted AI platform for governed autonomous finance, today announced...

IIFL Capital partners with Flytxt to leverage Agentic AI for sustainable AUM growth

IIFL Capital partners with Flytxt to leverage Agentic AI for sustainable AUM growth

MUMBAI, India, Aug. 6, 2026 /PRNewswire/ -- Flytxt, a leading provider of Enterprise AI solutions for Marketplace Optimisation, today announced that IIFL Capital Services Limited, a full-service investment and wealth management firm, has adopted its...

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model CAMBRIDGE, Mass. and TAIPEI, July 15, 2026 /PRNewswire/ -- Insilico...

At the forefront of AI and digital innovation in higher education

At the forefront of AI and digital innovation in higher education

Honoured with two major industry awards recognising sustained excellence in AI innovation and digital transformation, reinforcing its commitment to future-ready education. SINGAPORE, May 22, 2026 /PRNewswire/ -- Kaplan Higher Education Academy...

Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI

Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI

SUZHOU, China, May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine ("Insilico", 03696.HK). Both parties will...

Blaize Announces Pricing of $35 Million Public Offering of Common Stock

Blaize Announces Pricing of $35 Million Public Offering of Common Stock

EL DORADO HILLS, Calif., May 6, 2026 /PRNewswire/ -- Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) ("Blaize," the "Company," "we," "our," or "us"), a leader in programmable, energy-efficient AI computing, announced today the pricing of its...

Blaize and Nokia Advance Collaboration with Joint AI Solution Showcase at GITEX Asia

Blaize and Nokia Advance Collaboration with Joint AI Solution Showcase at GITEX Asia

EL DORADO HILLS, Calif. and SINGAPORE, March 31, 2026 /PRNewswire/ -- Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) ("Blaize"), a global leader in programmable, energy efficient AI computing, today announced the next phase of its collaboration...

NYSE Content Update: Snowflake to Unveil AI Platform to Get Work Done Faster

NYSE Content Update: Snowflake to Unveil AI Platform to Get Work Done Faster

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 18, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE...

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

CAMBRIDGE, Mass., Feb. 10, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an...

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks...

  • 1
  • 2
  • menu
    menu